BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 15471187)

  • 1. Cervical disease screening and detection: emerging techniques in molecular diagnostic assays.
    Rosenthal DL
    MLO Med Lab Obs; 2004 Sep; 36(9):10-1, 14-6; quiz 18-9. PubMed ID: 15471187
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular profiling of cervical neoplasia.
    Martin CM; Astbury K; O'Leary JJ
    Expert Rev Mol Diagn; 2006 Mar; 6(2):217-29. PubMed ID: 16512781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic tests for HPV infection.
    Chin-Hong PV; Klausner JD
    MLO Med Lab Obs; 2004 Oct; 36(10):10-2, 14-6; quiz 18-9. PubMed ID: 15536803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of polymerase chain reaction (PCR) method and hybrid capture II (HCII) assay for the detection of human papillomavirus in cervical scrapings.
    Saini R; Shen TH; Othman NH; Santhanam J; Othman N; Tang TH
    Med J Malaysia; 2007 Aug; 62(3):206-9. PubMed ID: 18246908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digene's chairman/CEO Evan Jones. Interview by Carren Bersch.
    Jones E
    MLO Med Lab Obs; 2003 Jul; 35(7):26, 28. PubMed ID: 12889227
    [No Abstract]   [Full Text] [Related]  

  • 6. [Assessment of human papilloma virus (HPV) testing in primary screening for cervical cancer in France (May 2004). Gynecol Obstet Fertil 2005;33:357-360].
    Monsonego J
    Gynecol Obstet Fertil; 2005 Nov; 33(11):952-5. PubMed ID: 16243571
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cervical cancer screening: restoration or reconstruction?].
    Riethmuller D
    Gynecol Obstet Fertil; 2009; 37(7-8):671-9. PubMed ID: 19577501
    [No Abstract]   [Full Text] [Related]  

  • 8. More than just a test result: molecular screening of human papilloma virus for contemporary management of cervical cancer risk.
    McGowin CL; Rohde RE; Redwine G
    Clin Lab Sci; 2014; 27(1):43-6. PubMed ID: 24669446
    [No Abstract]   [Full Text] [Related]  

  • 9. Detecting high-risk human papillomavirus in liquid-based cytology specimens.
    Qureshi MN
    Acta Cytol; 2005; 49(5):582. PubMed ID: 16334042
    [No Abstract]   [Full Text] [Related]  

  • 10. Chapter 10: New dimensions in cervical cancer screening.
    Cuzick J; Mayrand MH; Ronco G; Snijders P; Wardle J
    Vaccine; 2006 Aug; 24 Suppl 3():S3/90-7. PubMed ID: 16950022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus and cervical disease in adolescents.
    Guido R
    Clin Obstet Gynecol; 2008 Jun; 51(2):290-305. PubMed ID: 18463460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why do we go on screening?
    Marsan C
    Pol J Pathol; 2005; 56(4):167-9. PubMed ID: 16477875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cervical cancer screening: a new tool to do one's best or doing one's best with a new tool?].
    Lavoué V; Levêque J
    Gynecol Obstet Fertil; 2009; 37(7-8):680-2. PubMed ID: 19574078
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular HPV typing as a diagnostic tool to discriminate primary from metastatic squamous cell carcinoma of the lung.
    Weichert W; Schewe C; Denkert C; Morawietz L; Dietel M; Petersen I
    Am J Surg Pathol; 2009 Apr; 33(4):513-20. PubMed ID: 19145203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical cancer screening in pregnancy.
    McIntyre-Seltman K; Lesnock JL
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):645-58; x. PubMed ID: 19061823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple biomarkers in molecular oncology. I. Molecular diagnostics applications in cervical cancer detection.
    Malinowski DP
    Expert Rev Mol Diagn; 2007 Mar; 7(2):117-31. PubMed ID: 17331061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma.
    Lie AK; Kristensen G
    Expert Rev Mol Diagn; 2008 Jul; 8(4):405-15. PubMed ID: 18598223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus testing for primary cervical cancer screening.
    Grce M; Davies P
    Expert Rev Mol Diagn; 2008 Sep; 8(5):599-605. PubMed ID: 18785808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Objective screening for cervical cancer in developing nations: lessons from Nigeria.
    Roblyer D; Richards-Kortum R; Park SY; Adewole I; Follen M
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S94-7. PubMed ID: 17825396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus: the burden of infection.
    Wiley D; Masongsong E
    Obstet Gynecol Surv; 2006 Jun; 61(6 Suppl 1):S3-14. PubMed ID: 16729902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.